Also trades as: CLNNW (NASDAQ) · $vol 0M
CLNN NASDAQ
Clene Inc.
1W: -3.5%
1M: -0.2%
3M: -30.9%
YTD: -28.1%
1Y: -40.5%
3Y: -60.7%
5Y: -97.1%
$4.08
+0.06 (+1.49%)
Weekly Expected Move ±14.7%
$3
$4
$4
$5
$5
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
20 relationships20
As Filer
counterparties named
0
As Counterparty
mentioned by others
3
Rel. Types
2021-05-24
Earliest Filing
2026-03-17
Latest Filing
partner: 14
investor: 4
supplier: 2
Counterparties (Filed by CLNN)
20 relationshipsCompanies named in CLNN's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| New York University | — | partner | Prime awardee for Year 3 NIH Grant subaward | 2026-03-17 | View |
| Columbia University | — | partner | Prime awardee for Year 1 and Year 2 NIH Grant subawards | 2026-03-17 | View |
| BTIG, LLC | — | partner | Placement Agent for the securities offering | 2026-01-13 | View |
| Canaccord Genuity LLC | — | partner | Placement agent for the equity distribution agreement | 2025-04-28 | View |
| Columbia University | — | partner | Prime awardee of NIH Grant and subaward partner for ACT-EAP program | 2025-01-30 | View |
| Synapticure | — | partner | Neurology specialty health clinic collaborating on NIH Grant | 2025-01-30 | View |
| Colombia University | — | partner | Prime awardee of NIH Grant and counterparty to the Subaward agreement. | 2024-04-09 | View |
| Canaccord Genuity LLC | — | partner | Sole bookrunner and underwriter for the equity offering | 2023-06-16 | View |
| Maxim Group LLC | MMS | partner | Co-manager for the equity offering | 2023-06-16 | View |
| EF Hutton | — | partner | Co-manager for the equity offering | 2023-06-16 | View |
| Benchmark Investments, LLC | — | partner | Parent entity of EF Hutton division acting as co-manager | 2023-06-16 | View |
| Lincoln Park Capital Fund, LLC | — | investor | Lincoln Park Capital Fund, LLC committed to purchase up to $25,000,000 of Clene Inc.'s common stock under a purchase agr | 2023-03-03 | View |
| Canaccord Genuity LLC | — | partner | Placement agent for equity distribution | 2022-04-14 | View |
| Oppenheimer & Co. Inc. | OPY | partner | Placement agent for equity distribution | 2022-04-14 | View |
| 100 Chesapeake Blvd LLC | — | supplier | Landlord for the Elkton Lease facility | 2021-08-11 | View |
| Upper Chesapeake Flex One, LLC | — | supplier | Landlord for the New Principio Lease facility | 2021-08-11 | View |
| Avenue Capital Group | — | partner | Parent entity of the lender Avenue Venture Opportunities Fund, L.P. | 2021-05-24 | View |
| Symbiosis II, LLC | — | investor | Investor in the private placement PIPE. | 2021-05-24 | View |
| WIT, LLC | — | investor | Affiliated entity with Symbiosis II, LLC that invested in the private placement. | 2021-05-24 | View |
| Kensington Clene 2021, LLC | — | investor | Investor in the private placement PIPE. | 2021-05-24 | View |
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-09-16 | Material Agreement; Other Events; Exhibits | Agreement | View |
| 2026-08-14 | Earnings Release; Exhibits | View | |
| 2026-08-10 | Regulation FD; Other Events; Exhibits | View | |
| 2026-05-22 | Material Agreement; Officer/Director Change; Shareholder Vote; Exhibits | Agreement | View |
| 2026-05-14 | Material Agreement; Earnings Release; Exhibits | Agreement | View |
| 2026-05-05 | Material Agreement; Other Events; Exhibits | Agreement | View |
| 2026-05-04 | Regulation FD; Other Events; Exhibits | View | |
| 2026-03-17 | Entry into Material Definitive Agreement; Financial Statements and Exhibits | Agreement | View |
| 2026-03-12 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2026-02-24 | Other Events; Financial Statements and Exhibits | View | |
| 2026-01-13 | Entry into Material Definitive Agreement; Other Events; Financial Statements and Exhibits | Agreement | View |
| 2026-01-12 | Other Events; Financial Statements and Exhibits | View | |
| 2025-12-03 | Other Events; Financial Statements and Exhibits | View | |
| 2025-12-03 | Regulation FD Disclosure; Financial Statements and Exhibits | View | |
| 2025-11-13 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-10-17 | Other Events; Financial Statements and Exhibits | View | |
| 2025-10-14 | Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and Ex | View | |
| 2025-09-25 | Regulation FD Disclosure; Other Events; Financial Statements and Exhibits | View | |
| 2025-09-05 | Other Events; Financial Statements and Exhibits | View | |
| 2025-08-14 | Entry into Material Definitive Agreement; Results of Operations and Financial Condition; Creation of | Agreement | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR